Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 63 | 2021 | 2324 | 3.290 |
Why?
|
| Pulmonary Embolism | 18 | 2015 | 253 | 2.080 |
Why?
|
| Coronary Angiography | 31 | 2014 | 866 | 2.020 |
Why?
|
| Coronary Artery Disease | 16 | 2014 | 696 | 1.110 |
Why?
|
| Tomography, Spiral Computed | 5 | 2007 | 57 | 1.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 21 | 2014 | 373 | 0.940 |
Why?
|
| Pulmonary Artery | 6 | 2011 | 323 | 0.770 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2013 | 333 | 0.670 |
Why?
|
| Contrast Media | 19 | 2015 | 595 | 0.650 |
Why?
|
| Cloud Computing | 1 | 2017 | 4 | 0.610 |
Why?
|
| Relative Value Scales | 1 | 2017 | 8 | 0.610 |
Why?
|
| Radiologists | 1 | 2017 | 35 | 0.590 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 61 | 0.580 |
Why?
|
| Workload | 1 | 2017 | 103 | 0.560 |
Why?
|
| Angiography | 6 | 2011 | 194 | 0.540 |
Why?
|
| Myocardial Perfusion Imaging | 5 | 2011 | 100 | 0.510 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2014 | 79 | 0.470 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2015 | 689 | 0.470 |
Why?
|
| Electrocardiography | 12 | 2014 | 601 | 0.440 |
Why?
|
| Coronary Stenosis | 7 | 2010 | 246 | 0.430 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 4 | 2011 | 137 | 0.430 |
Why?
|
| Radiation Dosage | 4 | 2011 | 419 | 0.410 |
Why?
|
| Sensitivity and Specificity | 20 | 2012 | 1753 | 0.410 |
Why?
|
| Heart Diseases | 3 | 2014 | 276 | 0.400 |
Why?
|
| Middle Aged | 47 | 2021 | 21147 | 0.400 |
Why?
|
| Radiographic Image Enhancement | 11 | 2011 | 208 | 0.400 |
Why?
|
| Radiography, Thoracic | 4 | 2005 | 99 | 0.390 |
Why?
|
| Algorithms | 10 | 2015 | 1196 | 0.370 |
Why?
|
| Humans | 76 | 2021 | 68618 | 0.360 |
Why?
|
| Lung | 5 | 2004 | 849 | 0.330 |
Why?
|
| Risk Assessment | 7 | 2015 | 2007 | 0.330 |
Why?
|
| Coronary Disease | 6 | 2014 | 358 | 0.330 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2007 | 75 | 0.300 |
Why?
|
| Chest Pain | 5 | 2014 | 151 | 0.300 |
Why?
|
| Male | 48 | 2021 | 37321 | 0.300 |
Why?
|
| Models, Statistical | 1 | 2011 | 448 | 0.290 |
Why?
|
| Female | 48 | 2016 | 38074 | 0.290 |
Why?
|
| Coronary Vessels | 4 | 2015 | 313 | 0.280 |
Why?
|
| Software | 5 | 2014 | 418 | 0.270 |
Why?
|
| Predictive Value of Tests | 10 | 2015 | 1465 | 0.260 |
Why?
|
| Calcinosis | 4 | 2012 | 241 | 0.260 |
Why?
|
| Bronchography | 1 | 2004 | 5 | 0.240 |
Why?
|
| Mediastinitis | 1 | 2004 | 4 | 0.240 |
Why?
|
| Bronchi | 1 | 2004 | 59 | 0.230 |
Why?
|
| Reproducibility of Results | 15 | 2014 | 2077 | 0.230 |
Why?
|
| Heart | 1 | 2008 | 850 | 0.230 |
Why?
|
| Aged | 25 | 2015 | 14862 | 0.220 |
Why?
|
| Exercise Test | 3 | 2014 | 242 | 0.210 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2015 | 117 | 0.210 |
Why?
|
| Myocardium | 1 | 2008 | 1204 | 0.210 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2002 | 8 | 0.200 |
Why?
|
| Emphysema | 1 | 2002 | 32 | 0.200 |
Why?
|
| Phantoms, Imaging | 3 | 2015 | 189 | 0.200 |
Why?
|
| Adult | 24 | 2016 | 21403 | 0.190 |
Why?
|
| Pneumonectomy | 1 | 2002 | 79 | 0.190 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 70 | 0.190 |
Why?
|
| Adipose Tissue | 2 | 2013 | 221 | 0.180 |
Why?
|
| Stents | 4 | 2015 | 657 | 0.180 |
Why?
|
| Acute Disease | 8 | 2015 | 658 | 0.180 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1173 | 0.180 |
Why?
|
| Retrospective Studies | 16 | 2021 | 7277 | 0.170 |
Why?
|
| Ventricular Function, Right | 2 | 2011 | 103 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 300 | 0.160 |
Why?
|
| Iohexol | 4 | 2013 | 82 | 0.150 |
Why?
|
| Thrombophlebitis | 4 | 2004 | 47 | 0.140 |
Why?
|
| Myocardial Ischemia | 2 | 2008 | 172 | 0.140 |
Why?
|
| Hemangiosarcoma | 1 | 2016 | 23 | 0.140 |
Why?
|
| Cardiac-Gated Imaging Techniques | 3 | 2013 | 60 | 0.130 |
Why?
|
| Heart Neoplasms | 1 | 2016 | 33 | 0.130 |
Why?
|
| Artifacts | 4 | 2009 | 125 | 0.130 |
Why?
|
| Multidetector Computed Tomography | 2 | 2015 | 60 | 0.130 |
Why?
|
| Heart Atria | 1 | 2016 | 206 | 0.130 |
Why?
|
| Diagnosis, Differential | 5 | 2009 | 1140 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 940 | 0.120 |
Why?
|
| Diagnostic Errors | 2 | 2005 | 100 | 0.120 |
Why?
|
| Iopamidol | 3 | 2012 | 37 | 0.120 |
Why?
|
| Hypertrophy, Right Ventricular | 2 | 2004 | 21 | 0.120 |
Why?
|
| Observer Variation | 5 | 2013 | 330 | 0.120 |
Why?
|
| Thoracic Diseases | 1 | 2014 | 10 | 0.120 |
Why?
|
| Cause of Death | 1 | 2015 | 241 | 0.120 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 35 | 0.110 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 2 | 2014 | 92 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2014 | 97 | 0.110 |
Why?
|
| Pulmonary Veins | 2 | 2004 | 56 | 0.110 |
Why?
|
| Patient Selection | 2 | 2007 | 592 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2013 | 31 | 0.110 |
Why?
|
| Pericardium | 1 | 2013 | 97 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 125 | 0.110 |
Why?
|
| Chi-Square Distribution | 5 | 2012 | 546 | 0.100 |
Why?
|
| Statistics, Nonparametric | 5 | 2012 | 306 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2009 | 4848 | 0.100 |
Why?
|
| Blood Volume | 1 | 2011 | 47 | 0.100 |
Why?
|
| Body Burden | 1 | 2011 | 27 | 0.090 |
Why?
|
| Coronary Circulation | 1 | 2011 | 136 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 1851 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2010 | 27 | 0.090 |
Why?
|
| Synovial Cyst | 2 | 1981 | 4 | 0.090 |
Why?
|
| Equipment Design | 2 | 2010 | 500 | 0.090 |
Why?
|
| Gout | 2 | 1981 | 9 | 0.090 |
Why?
|
| Adenosine | 1 | 2010 | 165 | 0.090 |
Why?
|
| Professional Competence | 1 | 2011 | 100 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2014 | 166 | 0.090 |
Why?
|
| Knee Joint | 2 | 1981 | 115 | 0.090 |
Why?
|
| Regression Analysis | 4 | 2013 | 737 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2008 | 705 | 0.080 |
Why?
|
| Papillary Muscles | 1 | 2008 | 30 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2008 | 15 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2007 | 652 | 0.080 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.070 |
Why?
|
| Heart Rate | 1 | 2010 | 568 | 0.070 |
Why?
|
| Creatinine | 1 | 2008 | 243 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2011 | 2358 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2009 | 222 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2009 | 164 | 0.070 |
Why?
|
| Thrombolytic Therapy | 2 | 2009 | 233 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 274 | 0.070 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 114 | 0.070 |
Why?
|
| Lung Diseases | 2 | 2005 | 175 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2007 | 93 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 225 | 0.070 |
Why?
|
| Radiation Protection | 1 | 2007 | 71 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2021 | 1342 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 167 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2008 | 204 | 0.070 |
Why?
|
| Syringes | 1 | 2006 | 15 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2006 | 136 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 307 | 0.060 |
Why?
|
| Triage | 1 | 2005 | 109 | 0.060 |
Why?
|
| Syncope, Vasovagal | 1 | 2004 | 5 | 0.060 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 58 | 0.060 |
Why?
|
| Syncope | 1 | 2004 | 23 | 0.060 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 33 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 41 | 0.060 |
Why?
|
| Prognosis | 4 | 2015 | 2093 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 22 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2004 | 57 | 0.060 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2004 | 50 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 236 | 0.060 |
Why?
|
| Sarcoma, Synovial | 1 | 2003 | 11 | 0.060 |
Why?
|
| Isotopes | 1 | 2003 | 15 | 0.060 |
Why?
|
| Helium | 1 | 2003 | 9 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 383 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 79 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2005 | 238 | 0.050 |
Why?
|
| Fibrosis | 1 | 2004 | 371 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 453 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 843 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2003 | 125 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 38 | 0.050 |
Why?
|
| Adolescent | 4 | 2009 | 8912 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2008 | 3187 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 81 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 2223 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 160 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2021 | 258 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2003 | 232 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2010 | 219 | 0.040 |
Why?
|
| Heart Failure | 1 | 2008 | 1180 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2015 | 714 | 0.040 |
Why?
|
| Biomarkers | 1 | 2004 | 1593 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 159 | 0.040 |
Why?
|
| Risk Factors | 3 | 2014 | 5731 | 0.040 |
Why?
|
| ROC Curve | 2 | 2011 | 392 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2011 | 3705 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 2011 | 218 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2009 | 504 | 0.030 |
Why?
|
| Hematemesis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 792 | 0.030 |
Why?
|
| Hemoptysis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 242 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2014 | 27 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 274 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 320 | 0.030 |
Why?
|
| Software Design | 1 | 2013 | 18 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 301 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 880 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 277 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 438 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2011 | 24 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 4655 | 0.020 |
Why?
|
| Computer Systems | 1 | 2010 | 42 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1603 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.020 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2009 | 2 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1038 | 0.020 |
Why?
|
| Metals | 1 | 2010 | 100 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 133 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2009 | 106 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1981 | 157 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.020 |
Why?
|
| Warfarin | 1 | 2009 | 93 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 21 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 3259 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2008 | 102 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 134 | 0.020 |
Why?
|
| Movement | 1 | 2009 | 179 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 215 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 563 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 237 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 148 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 572 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1619 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 371 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2009 | 356 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 554 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1420 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1040 | 0.020 |
Why?
|
| Calcium | 1 | 2009 | 929 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 87 | 0.020 |
Why?
|
| Life Tables | 1 | 2004 | 29 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2007 | 419 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 245 | 0.020 |
Why?
|
| Granuloma | 1 | 2004 | 21 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2009 | 7029 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2004 | 122 | 0.010 |
Why?
|
| Aortography | 1 | 2004 | 72 | 0.010 |
Why?
|
| South Carolina | 1 | 2011 | 2752 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 711 | 0.010 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2004 | 134 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 2455 | 0.010 |
Why?
|
| Infant | 1 | 2008 | 2891 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 1426 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 446 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|
| Child | 1 | 2008 | 6405 | 0.010 |
Why?
|
| United States | 1 | 2008 | 7367 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 20881 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 1667 | 0.010 |
Why?
|